Anti-HRAS Antibody (Clone#BEA-8)

50μl/1280 100μl/2180 150μl/2800

C BAS/HAS; C H RAS; C HA RAS1; CTLO; GTPase HRas; H Ras 1; H RASIDX; Ha Ras; HAMSV; HRAS; HRAS1; HRAS-Specific; K RAS; RASH1; Transforming protein p21

Monoclonal

human, mouse, rat

WB, ICC/IF, IP, FCM

HRAS

BEA-8

Rabbit

IgG

A synthesized peptide derived from human GTPase HRAS

21 kDa

21 kDa

500 ug/ml; Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide, 0.4-0.5 mg/ml BSA and 50% glycerol.

Affinity-chromatography

500 ug/ml

Liquid

12 months from date of receipt，-20℃ as supplied.

GTPase HRas, also known as transforming protein p21, is an enzyme that in humans is encoded by the HRAS gene. This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, mental retardation, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene.

P01112  

HRAS Antibody (Clone#BEA-8) (Boster Biological Technology, Wuhan, China. Catalog#BM4106)

WB-蛋白质免疫印迹法; IHC- 免疫组织化学法; ICC/IF-免疫细胞荧光和免疫细胞化学; FCM-流式细胞术; ELISA-酶联免疫吸附测定; IP-免疫沉淀法; IF-免疫组织荧光法; ChIP-染色质免疫沉淀法;

GTPase HRas

Western blot (WB):	1:500-2000
Immunocytochemistry/Immunofluorescence (ICC/IF):	1:50-200
ImmunoPrecipitation (IP):	1:20
Flow Cytometry (FCM):	1:20